Actively Recruiting
Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
Led by Jose Ivan Rodriguez de Molina Serrano · Updated on 2025-09-16
100
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinical resolution or hospital discharge.
CONDITIONS
Official Title
Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged ≥5 years
- Laboratory-confirmed dengue infection (NS1, IgM, or PCR)
- First contact at emergency or outpatient services
- Informed consent signed by the patient or legal guardian
You will not qualify if you...
- Co-infection with other arboviruses or COVID-19
- Pre-existing hematologic or oncologic disease
- Refusal to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinica Mexico
Piedras Negras, Coahuila, Mexico, 26000
Actively Recruiting
Research Team
J
JOSE IVAN RODRIGUEZ DE MOLINA SERRANO, MD, MSc, Ph, Specialist
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here